
Benefits & Risks of Peptide Therapeutics for Physical & Mental Health
What this covers
Huberman surveys the major classes of therapeutic peptides now in use for tissue repair, muscle growth, mood enhancement, and longevity, explaining how each works at the cellular level and what evidence supports or limits their use. The episode maps four primary peptide categories—BPC-157, growth hormone secretagogues, epithalon, and melanocortin agonists—along with emerging options like kisspeptin. Huberman's central claim is that peptides are potent, pleiotropic compounds whose real risks remain obscured by an evidence base built almost entirely on animal studies and user reports rather than human clinical trials, and that treatment requires physician oversight, clean sourcing, and realistic assumptions about safety.
The episode distinguishes peptide categories by mechanism and evidence tier. Growth hormone secretagogues split into two types: GHRH-mimicking peptides like sermorelin and tesamorelin, which have human trial data and FDA approval for specific indications, versus ghrelin-mimicking peptides like hexarelin and MK-677, which are more potent but increase hunger, cortisol, and prolactin and carry desensitization risk. BPC-157 exemplifies the evidence gap—decades of peer-reviewed animal work showing tissue repair through angiogenesis, yet no credible human trials and thus no way to rule out placebo. The discussion of sourcing and side effects turns especially cautionary: peptides from gray or black markets often carry lipopolysaccharide contamination; combining different peptides requires careful dosing to avoid redundant pathway activation; and augmenting growth factors and angiogenesis carries real tumor and cancer growth risk that receives little public attention, particularly when BPC-157 is stacked with growth-hormone-raising compounds. The episode also covers dosing protocols, cycling schedules, routes of administration, and which peptides require the most physician monitoring, framing the field as early-stage despite its rapid expansion.
Huberman provides a comprehensive framework for understanding therapeutic peptides—their mechanisms, categories, potential benefits, and risks—emphasizing that despite widespread use, peptides are potent compounds with pleiotropic effects that require physician oversight, clean sourcing, and careful monitoring for safety.
- Peptides have multiple simultaneous effects across different tissues and cell types (pleiotropic), making them fundamentally different from single-target compounds
- Most therapeutic peptides lack human clinical trial data despite millions of people using them based on animal studies and anecdotes
- Peptide sourcing and purity are critical safety factors—gray market and black market peptides often contain dangerous contaminants like LPS that accumulate over time
This asset isn't compiled yet
You're seeing its claims, ranked. Compile it to build the argument threads, weight them, and check each claim against your library — the full view.
Most peptides, especially therapeutic peptides, have pleiotropic effects, meaning a single peptide activates many different cellular pathways and affects many cell types and organ systems depending on cell type, time of day, and downstream effects, so there is no way to obtain a targeted single-pathway effect without activating other pathways.
“always, always, always, if you take peptides, especially therapeutic peptides, designed to promote activity within a given pathway for a specific purpose, you are going to activate other pathways as well. There's simply no way to remove the pleiotropic feature of peptide therapeutics.”
The melanotan peptides (1 through 5) all mimic melanocyte-stimulating hormone and cause skin darkening, but melanotan 1 does not cross the blood-brain barrier (only tanning), whereas melanotan 2-5 cross it and additionally increase mood and libido and decrease appetite; PT-141 (the FDA-approved drug Vyleesi) targets this system and is approved for premenopausal hypoactive sexual desire in women but is used off-label in men.
“melanotan 1 does not cross the blood-brain barrier. It does however stimulate the melanocytes of the skin... Melanotan 2 3 4 and 5 also lead to darkening of the skin... but because they can cross the blood-brain barrier they cause effects that are at the level of psychology”
The melanocortin system links light exposure (UVB sunlight to eyes or skin) through the hypothalamus and pituitary to release of melanocyte-stimulating hormone, causing skin pigmentation while in parallel stimulating dopamine release; this conserved system explains why people and animals feel better, have more energy/libido, and (in animals) darken pelage and breed when sunlight increases in spring.
“There's also a pathway whereby the light stimulates the melanocyte-stimulating hormone system, and in parallel stimulates the release of dopamine.”
Despite a large peer-reviewed animal literature dating back to about 1993, there is essentially no human clinical trial data on BPC-157 (only one poor self-report study), so it is impossible to rule out that its widely reported benefits are robust placebo effects, even though anecdotal reports from hundreds of thousands to millions of users are unusually strong.
“To my knowledge, there is only one study on humans, and it's not a clinical trial, and frankly, it's not the best performed study”
Despite clear understanding of the kisspeptin pathway's role in reproduction and the fact that synthetic kisspeptin mimics a naturally occurring peptide with constrained functions, kisspeptin peptides have pleiotropic effects that are not yet fully understood, making their use for vitality and libido enhancement a 'wild card' with unknown long-term consequences.
“I will say despite the fact that the kisspeptin pathway is well known, and despite the fact that the kisspeptin peptide is designed to mimic a naturally occurring peptide that has a pretty constrained set of functions in the hypothalamic pituitary system and their downstream effects on the gonads, the use of kisspeptin to increase vitality and libido is a bit of a um let's just say it's a it's a little bit of a wild card. We don't yet know all the effects of kisspeptin.”
Most peptides have pleiotropic effects, meaning they affect many different aspects of cells and tissues across different cell types, depending on the cell type, time of day, and downstream effects, making peptides fundamentally different from single-target compounds like dopamine or testosterone.
“most peptides have what are called pleiotropic effects, meaning they affect many different aspects of cells. And this is very important to understand because, unlike a lot of our discussion on this podcast about dopamine or about specific hormones like testosterone or estrogen. When we talk about peptides, especially therapeutic peptides, often times we're talking about a single peptide that does a bunch of different things depending on the cell type, the time of day or night that that peptide is present, and even the different so-called downstream effects of the peptide.”
Growth hormone secretagogue peptides fall into two categories: 'type one' GHRH-mimicking peptides (sermorelin, tesamorelin, CJC-1295) which are mostly human-tested and in several cases FDA-approved, and 'type two' growth-hormone-releasing peptides (ipamorelin, hexarelin, GHRP-2/3/6, MK-677) which act by mimicking or stimulating ghrelin and thus also increase hunger and anxiety.
“These peptides encourage the release of growth hormone, but they do so either by mimicking or stimulating the release of another peptide called ghrelin.”
Lipopolysaccharide (LPS) can accumulate during peptide manufacturing and causes an immune response; while a tiny amount may not cause a massive response, repeated exposures accumulate and become problematic, which is why properly cleaned (LPS-removed) peptides from pharma or compounding pharmacies are safer than gray/black-market sources.
“The reason is that LPS causes an immune response. And while a tiny amount of LPS might not cause a massive immune response, the accumulation of many, many LPS exposures can start to become problematic.”
Applied therapeutic peptides fall into three categories: prescription FDA-approved peptides from board-certified physicians (the safest), gray-market peptides purchasable online with questionable safety/efficacy, and black-market peptides which are often contaminated and not what they claim to be; the safest path is prescription peptides because they are cleaned of lipopolysaccharide (LPS).
“There are peptides that are being prescribed by physicians... There are other peptides that reside in kind of a gray market area... And then of course there's the black market peptides.”
Taking growth hormone directly carries common risks including carpal tunnel syndrome, cartilage overgrowth, structural changes to the head, face and body (brow thickening), a lean-but-distended gut, and unusual skin texture; growth-hormone-promoting peptides produce less dramatic structural changes than direct growth hormone.
“When people take growth hormone itself, there are common risks such as carpal tunnel syndrome... There can be active changes in the structure of one's head and face and body.”
Growth hormone secretagogue peptides should be taken about 20-30 minutes before sleep, at least an hour and a half (preferably two hours) after eating and with no food for at least 30 minutes afterward, because elevated blood sugar or food in the gut blunts their growth-hormone- and IGF-1-raising effect, and bedtime timing augments the natural early-night growth hormone pulse.
“Always it's suggested that they be taken at least an hour and a half after eating any food and that you don't eat for at least 30 minutes afterwards because if you happen to have elevated blood sugar or you've got food in your gut, they're not going to have as potent an effect at increasing growth hormone and IGF-1.”
Growth hormone is secreted by the pituitary gland under control of the hypothalamus, is released most heavily during early sleep, and declines by about 15% per decade after age 30; this decline reduces growth hormone's effects on metabolism, fat loss, muscle growth, mood, vitality, and ATP/energy production, motivating interest in augmenting it.
“typically after 30, the amount of growth hormone that's released each night and throughout the day is reduced by about 15% for every decade of life.”
People tend to wrongly assume peptides are inherently safe or free of side effects because they are not hormone therapies like testosterone or estrogen therapy; in fact peptides are very potent compounds with many pleiotropic effects, peptide therapeutics are in early stages, and they carry real risks requiring physician oversight, clean sourcing, regular blood testing, and tumor monitoring.
“people, I think, inadvertently assume that peptides are all safe or innocuous... that because they're not hormone therapies per se, that they are free of side effects and risk.”
Kisspeptin is a recently discovered peptide made in the brain that sits at the top of the reproductive hormone cascade — it turns on GnRH, which triggers LH and FSH release from the pituitary, which in turn stimulate the gonads to produce testosterone and estrogen and drive sperm/follicle development; synthetic kisspeptin is prescribed for hypothalamic amenorrhea and used off-label to boost vitality and libido, while kisspeptin antagonists treat menopausal vasomotor symptoms.
“the signal that turns on GnRH is kisspeptin. Kisspeptin, in other words, is further upstream from GnRH and LSH and FSH. It's a cascade. It goes kisspeptin, GnRH, LH, FSH, testosterone, estrogen.”
There are three sources of therapeutic peptides: FDA-approved prescription peptides from physicians, gray market peptides available online with questionable safety and efficacy, and black market peptides often contaminated with harmful substances like LPS (lipopolysaccharide) that create long-term health problems.
“There are peptides that are being prescribed by physicians. So these are prescription peptides for specific purposes. These are FDA approved. There are other peptides that reside in kind of a gray market area. You can purchase them online, but the safety and efficacy of those peptides is a bit questionable, in some cases very questionable...And then of course there's the black market peptides...many of them are contaminated with things that both in the short term, but especially in the long term, can be problematic.”
Hexarelin is the strongest stimulator of growth hormone release (pulses 2-3x larger than other secretagogues) but can dramatically increase prolactin (suppressing libido), cause fluid retention and malaise, and most problematically desensitize the growth-hormone-releasing-hormone receptors, potentially permanently turning off the system's response to any peptide or endogenous signal.
“Hexarelin can desensitize the receptors for growth hormone-releasing hormone, such that your system will no longer respond either to the Hexarelin or to any other peptide... you could essentially turn off the system permanently.”
Sermorelin (FDA-approved for short stature) and tesamorelin (brand Egrifta, FDA-approved for reducing visceral adiposity in HIV patients) are the most thoroughly tested type-one secretagogues; both increase circulating growth hormone and IGF-1 with both animal and human data, making them more advantageous options than CJC-1295, which had a cardiovascular death in a clinical trial and remains unresolved on safety.
“CJC-1295 has entered clinical trials. There was a death within one of the clinical trials that was related to cardiovascular dysfunction.”
Direct growth hormone injection is subject to negative feedback, where high blood levels cause the pituitary and brain to shut down endogenous growth hormone production; this drove the development of secretagogue peptides that stimulate the body's own growth hormone release by mimicking hypothalamic signals rather than directly supplying growth hormone.
“it is subject to what's called negative feedback. If your blood levels of growth hormone are too high by virtue of injecting growth hormone, well then the pituitary can register that and the brain can register that, and then there's a negative feedback that shuts down growth hormone.”
Thymosin beta 4 (and its truncated synthetic version TB-500) is a peptide naturally produced by the thymus, which is present in children and disappears with age; it promotes tissue repair by stimulating growth of multiple cell types, stem cell proliferation, and extracellular matrix growth, but unlike BPC-157 it is involved in tissue repair, not tissue growth, and does not impact the growth hormone pathway.
“thymosin beta 4 really promotes the growth and infiltration of all sorts of different cell types associated with tissue rejuvenation and especially wound healing and repair. It's been shown to promote stem cell proliferation.”
BPC-157 promotes tissue repair primarily by increasing blood flow to injury sites through angiogenesis: it recognizes injured blood vessels and capillaries and upregulates the enzyme eNOS (endothelial nitric oxide synthase), causing new vasculature to form, which delivers growth factors that further rejuvenate tissue; it also encourages fibroblast migration and growth at the injury site.
“BPC 157 somehow is able to recognize injured blood vessels and injured capillaries and then to promote the activity of a given enzyme called eNOS or endothelial nitric oxide synthase, which then causes more blood vasculature to form at the injury site”
Lipopolysaccharide (LPS) is a contaminant that accumulates during peptide manufacturing and triggers immune responses; repeated LPS exposures can become problematic over time, making LPS removal critical for safe peptide use.
“sometimes these peptides come from pharma companies, other times they are made by a compounding pharmacy. But in both situations, they are cleaned of what's called lipopolysaccharide or LPS. LPS is something that can accumulate in the manufacturing process of some of these peptides, and it's something that you really want to remove from the peptide before you ingest it or inject it... LPS causes an immune response. And while a tiny amount of LPS might not cause a massive immune response, the accumulation of many, many LPS exposures can start to become problematic.”
BPC-157 has a very high safety profile in terms of lethal dosing, with an LD50 as high as 2 grams (2,000 mg) per kilogram of body weight; typical therapeutic doses are far lower, around 300-500 micrograms subcutaneously two to three times per week for about 8 weeks, followed by cycling off for 8-10 weeks.
“The LD50 of BPC 157 is incredibly high, okay? It is as high as 2 g, okay? 2 g, 2,000 mg, that is, per kilogram of body weight.”
Epitalon (epithalon) is a synthetic peptide designed to mimic epithalamin, a peptide naturally secreted by the pineal gland (which also produces melatonin); based largely on animal data it is taken as a longevity agent because it appears to suppress tumor growth, increase telomere length, exert anti-inflammatory effects, and recalibrate age-related circadian/melatonin disruptions, though the telomere-longevity link is controversial and no human clinical trials support life extension.
“Epithalon is a peptide that's secreted from the pineal gland... It also makes a peptide called epithalamin... it does appear to be able to adjust telomere length”
Type-two secretagogues like GHRP-3 and MK-677 (an oral, non-injectable GHRP) can potently increase growth hormone but also more than double circulating cortisol and elevate prolactin; because cortisol should be high in the morning and very low at night, and these peptides are taken before bed, the cortisol elevation can be problematic.
“Things like GHRP-3 can potently increase growth hormone, but are known to also potently increase prolactin and cortisol, leading to more than a doubling of circulating cortisol”
BPC-157 is a synthetic peptide manufactured to resemble body protection compound, a peptide that naturally occurs in the gut and is involved in wound healing and repair; its presence in the gut is plausibly linked to the high cellular turnover of gut tissue, which mirrors the cellular turnover involved in wound healing.
“that peptide is BPC, which stands for body protection compound 157. BPC 157 is a synthetic peptide. It's manufactured in a laboratory to resemble a peptide that exists naturally within our gut.”
Combining different growth-hormone-promoting peptides (e.g. sermorelin or tesamorelin with hexarelin, or ipamorelin with CJC-1295) is a legitimate strategy because different amino acid sequences stimulate different modes of action of the same target peptide, but relative dosing must be managed to avoid unnecessary prolactin/cortisol increases and redundant pathway hitting.
“While I'm not opposed to that approach, you just want to make sure that the dosing... of each peptide is such that... you're avoiding unnecessary increases in prolactin and cortisol, and that you're not hitting a pathway redundantly.”
Tesamorelin (brand name Egrifta) is FDA-approved for reduction of visceral adiposity in HIV patients, produces similar effects to sermorelin including increased deep sleep, is more long-lasting than sermorelin, and is typically taken 3 times per week rather than 5 times per week.
“tesamorelin...goes by the brand name Egrifta and it's an FDA approved drug for the reduction of visceral adiposity in HIV patients...has been shown to reduce visceral adiposity. It also seems to produce some of the other same effects that sermorelin produces...Tesamorelin is a bit more long-lasting than sermorelin and therefore is taken typically about three times per week, not five times per week.”
PT-141, also known as the prescription drug Vyleesi, is FDA-approved for treatment of premenopausal hypoactive sexual desire and activates the melanocortin system, but also stimulates skin pigmentation and can cause nausea, skin flushing, and blood pressure increases.
“PT-141 is also known as the prescription drug Vyleesi. PT-141 or Vyleesi is FDA approved for the treatment of premenopausal hypoactive sexual desire...Vyleesi will stimulate pigmentation. So, whether or not you consider that a side effect or a benefit depends on, I guess, your baseline level of pigmentation and how much level of pigmentation you actually want...some side effects associated with these compounds...One of the more common ones is nausea...can also cause flushing of the skin, and they can cause blood pressure to increase.”
Folks with melanoma should be very cautious about using melanocyte-stimulating peptides because stimulating melanocytes could potentially exacerbate melanoma.
“folks with melanoma should be very cautious about using any of the peptides that stimulate melanocytes because that could potentially exacerbate melanoma.”
Kisspeptin is prescribed for hypothalamic amenorrhea (loss/absence of menstrual cycles from hypothalamic deficits rather than ovarian or pituitary dysfunction), and kisspeptin antagonists are used to treat menopause symptoms including night sweats and vasomotor symptoms.
“it's actually prescribed for what's called hypothalamic amenorrhea. Hypothalamic amenorrhea is the loss or the absence of periods of menstrual cycles that are the consequence of deficits within the hypothalamus itself...there are also kisspeptin antagonists, okay, drugs that are designed to suppress kisspeptin, and those are used to treat some of the symptoms of menopause, including night sweats and some of the what are called vasomotor symptoms.”
BPC-157 poses a potential tumor growth risk because it upregulates growth hormone receptors and increases VEGF (vascular endothelial growth factor) to drive angiogenesis; tumors thrive on increased blood flow and growth factors, so BPC-157 may maintain or accelerate tumor growth — notably it does the exact opposite of the cancer drug Avastin, which is a VEGF inhibitor.
“if you have a tumor and tumors thrive on increased blood flow because they like to consume growth factors and increased blood flow means increased growth factors... by taking BPC 157 you may be either maintaining or accelerating the growth of a tumor”
Augmenting growth hormone — whether by direct synthetic growth hormone or by secretagogue peptides — increases tumor and cancer risk because growth hormone and IGF-1 are indiscriminate about which tissues they grow, so combining a GH-raising peptide with BPC-157 could potentially increase both the size and vascularization of an existing tumor.
“anytime we augment growth hormone... we are increasing our tumor growth risk and our cancer risk. And that's because growth hormone and IGF-1 are somewhat indiscriminate in terms of the tissues that they promote the growth of.”
Common risks of taking exogenous growth hormone or growth hormone-promoting peptides include carpal tunnel syndrome from cartilage growth, active changes in head and face structure, thickening of bone above the brow, a lean but distended gut appearance, and unusual skin texture.
“there are common risks such as carpal tunnel syndrome. Um that has to do in part with the fact that it can potently increase cartilage growth. There can be active changes in the structure of one's head and face and body...a kind of a thickening of the of the bone above the brow...people can get changes in the face...can really change one's stature and and shape uh to a considerable degree. It can also create a kind of a uh kind of a a skin texture that is a little bit unnatural or unusual.”
Many of the testimonials and reports about peptide effects are anecdotal rather than from rigorous clinical trials, which means we cannot definitively separate placebo effects from real pharmacological effects for most therapeutic peptides in humans.
“we're now in a situation where we don't know if we're dealing with pure placebo effect or we're we are dealing with real effects. And so, because of the lack of the human clinical studies, we don't know whether or not we're dealing with a situation of robust placebo effects... in the absence of clinical trials, we still don't know if and how they are working in humans.”
The LD50 (lethal dose) of BPC-157 is incredibly high at 2 g (2,000 mg) per kilogram of body weight, but this does not mean anyone should take high dosages of BPC-157, and typical therapeutic doses are far lower than this lethal threshold.
“The LD50 of BPC 157 is incredibly high, okay? It is as high as 2 g, okay? 2 g, 2,000 mg, that is, per kilogram of body weight. Now, that does not mean, please hear me on this, that does not mean that anyone should be taking high dosages of BPC 157.”
After approximately age 30, growth hormone release declines by about 15% for every decade of life, resulting in reduced effects on metabolism, fat loss, muscle growth, mood, and feelings of vitality as people age.
“after about age 30, which is typically when people experience their full stature, their full height...typically after 30, the amount of growth hormone that's released each night and throughout the day is reduced by about 15% for every decade of life. As a consequence, all of the things that growth hormone does like encouraging higher metabolism, fat loss, the growth of muscle tissue, etc., is dramatically reduced as we go from 30 to 40 to 50 and on and on.”
The melanocortin system is activated by viewing light or getting ultraviolet-B light on the skin, which stimulates signals from the eyes to the hypothalamus to the pituitary, leading to release of melanocyte-stimulating hormone that causes skin tanning and parallel dopamine release.
“The melanocortin system is a system whereby viewing light or getting light on the skin, typically ultraviolet light of the ultraviolet B type. Okay, there's two different types of ultraviolet light, but basically sunlight is what the system evolved to respond to, shown to the eyes and or to the skin stimulates the melanocortin system. It goes from the eyes to the hypothalamus, from the hypothalamus to the pituitary, and then the melanocyte-stimulating hormone is then released into the bloodstream, can travel to the melanocytes, and cause pigmentation of the skin...There's also a pathway whereby the light stimulates the melanocyte-stimulating hormone system, and in parallel stimulates the release of dopamine.”
Angiogenesis—the development of new vascular supply or blood supply through capillaries, veins, and arteries—is necessary for tissue rejuvenation and repair, and tissue rejuvenation involves the addition of new endothelial cells that make up the walls of blood vessels.
“anytime we're discussing tissue rejuvenation, that is cellular turnover or tissue repair...it almost certainly is going to involve angiogenesis, which is development of new vascular supply or blood supply...we're talking about the addition of new capillaries and or blood vessels. And that means the addition of new what are called endothelial cells, which are the cells that make up the walls of those blood vessels.”
Growth hormone promotes ATP production in cells, which increases energy metabolism and contributes to feelings of vitality and the motivation to do things, both mental and physical.
“growth hormone potently increases ATP production, which is involved in energy and metabolism in our cells and as a consequence our overall feelings of energy to just do things, mental or physical.”
Growth hormone is subject to negative feedback, whereby high blood levels of growth hormone trigger the pituitary and brain to suppress further growth hormone release, which led to the development of growth hormone-releasing peptides that stimulate growth hormone indirectly rather than directly.
“growth hormone is subject to what's called negative feedback. If your blood levels of growth hormone are too high by virtue of injecting growth hormone, well then the pituitary can register that and the brain can register that, and then there's a negative feedback that shuts down growth hormone. As a consequence, people have developed peptide therapeutics that stimulate the release of growth hormone...not by directly stimulating the growth hormone pathway...what these peptides are typically called are secretagogues.”
There is only one human study on BPC-157, which is not a clinical trial but rather self-reported recovery data from people who did or did not take BPC-157, making it a poorly performed study at best, while there are many peer-reviewed animal studies dating back to 1993.
“To my knowledge, there is only one study on humans, and it's not a clinical trial, and frankly, it's not the best performed study, and that's putting it mildly. It's more um kind of self-report of people recovering from a given injury, whether or not they took BPC 157 or they didn't.”
Animal studies show that epithalamin suppresses age-related ocular diseases, expands telomeres, and can partially offset several features of brain and body aging, but taking epithalamin to extend life is still largely based on connecting pieces from animal studies, pineal biology, and theoretical logic rather than direct clinical evidence.
“there's some interesting studies showing suppression of age-related ocular diseases. There's some nice studies showing telomere expansion. There's some nice studies showing that several features of brain and body aging can indeed be partially offset...it is indeed a leap that people are taking when they are deciding or taking epithalamin in order to extend their life, right? It's the logic is all there, but the pieces are sort of cludged together between what we know about the animal studies, what we know about the naturally occurring compounds that these peptides are designed to mimic and yet there are still no clinical trials that point directly to taking x amount of epithalamin several times per week as a way to extend life.”
Telomere length is thought to be associated with cell longevity, but the relationship between telomeres and longevity in humans is controversial: people were initially excited about this connection, then evidence challenged it, and now the field goes back and forth on whether telomere length predicts longevity.
“Keep in mind that the relationship between telomeres and longevity is a controversial one. People were very excited about this some years back, then people batted down that idea showing that telomere length was not associated with longevity, especially in humans, and now it's sort of a back and forth within the field.”
Thymosin beta 4 is naturally produced from the thymus, which is present in children and then disappears as people age, and children recover more quickly from injuries with less scarring than adults, suggesting thymosin beta 4 is involved in superior tissue healing in youth.
“thymosin beta 4 is something that the body produces naturally from this thing called the thymus, which is present in children and then disappears as we get older. And it's well known, again, this is correlative, but it's well known that children recover more quickly from injuries...the degree of tissue regrowth and the repair of wounds with minimal scarring is so much greater in young children and in children than it is in adults.”
In Huberman's own experience taking sermorelin one to two nights per week over a couple of years, it produced very deep early-night sleep but appeared to deplete rapid eye movement sleep (per his Eight Sleep and Whoop trackers), effectively replacing REM with deep sleep, which led him to largely stop taking it because both sleep types serve distinct essential functions.
“it seemed to sort of replace rapid eye movement sleep with more deep sleep. And rapid eye movement sleep is critical for all sorts of things that deep sleep can't achieve and vice versa.”
CJC-1295 is a variant of a growth hormone secreting peptide with a DAC (drug affinity complex) added to make it very long-lasting, allowing dosing only 1-2 times per week, but has entered clinical trials where a death related to cardiovascular dysfunction occurred, possibly linked to fluid retention and increased fluid volume.
“CJC-1295 is basically a variant of a different growth hormone secreting peptide that was synthesized previously to which they add what's called a DAC, a drug affinity complex. It's a sequence that makes it very long-lasting. So, CJC-1295 typically is only taken twice per week or even once per week...CJC-1295 has entered clinical trials. There was a death within one of the clinical trials that was related to cardiovascular dysfunction. It's known to cause some fluid retention and increased fluid volume, which may have been related to that cardiovascular death.”
It is essential to work with a physician who is very familiar with peptides and has extensive experience in the peptide space to understand how different peptides work alone and in combination.
“you want to make sure that you're working with someone who's very familiar with peptides. You know, really has been in the peptide space for a long time and understands how these things work alone and in combination.”
Receptor desensitization from Hexarelin is a major concern because it could permanently turn off the growth hormone-releasing hormone receptor pathway, making it critical to avoid high doses and long-term use of Hexarelin and to work with a physician while monitoring prolactin levels.
“If you're going to explore Hexarelin, make sure, please, that you're working with a physician. Make sure that you're not taking too much of it or for too long, and keep an eye on those prolactin levels because those can be problematic if they get too high. And, you know, by my read, I can't see why anyone would use high doses of Hexarelin.”
BPC-157 upregulates growth hormone receptors, which can be advantageous for injury healing by increasing growth hormone's action at injury sites, but in people with existing tumors, increased growth hormone receptors in and around the tumor could potentially increase tumor growth.
“BPC 157 is known to have a small, but nonetheless meaningful impact on upregulating growth hormone receptors...This can be a good thing if you're trying to upregulate growth hormone receptors at a given injury site...However, for some people, perhaps people who have a tumor in a given area, an increase in growth hormone receptors in and around the tumor could potentially increase the growth of the tumor.”
Due to confusing nomenclature in the literature, Huberman renames the two categories of growth hormone secretagogues as 'category one peptides' and 'category two peptides' to improve clarity, with category one peptides being more thoroughly tested in humans and FDA-approved for certain conditions.
“Rather than use that nomenclature, which is the typical nomenclature that's used...I'm going to call these are category one peptides and category two peptides. Okay? In general, category one peptides are going to be the ones that have been most thoroughly tested in humans, in some cases, in fact, in several cases, are FDA approved for certain conditions”
If younger than 30 years old, there is no good reason to augment growth hormone unless there is a clinical need or urgent need, because the person is already making a lot of natural growth hormone.
“if you're younger than 30, I don't know why you'd want to augment growth hormone unless you and your doctor decide that there's a clinical need or some other urgent need to do so because you're already making a lot of growth hormone.”
How BPC-157 exits the gut and gets trafficked to specific injured sites in the body still remains unclear, creating ongoing debate about whether systemic injection or oral administration is as effective as local injection directly at the injury site.
“what we haven't really addressed is if one has an injury, let's say to the hand or um to the arm, or to the leg, or to the ankle, or to the Achilles tendon, how is it that body protection compound that normally would exist within the gut actually access that injured tissue? Now, this still remains somewhat of a mystery. It is clear that BPC 157 can exit the gut, but how it gets trafficked to particular sites within the body that are injured still isn't clear.”
Thymosin beta 4 and TB-500 promote tissue healing by promoting stem cell proliferation, increasing growth of the extracellular matrix, and promoting aggregation of multiple cell types associated with tissue healing, rather than being growth-promoting like growth hormone.
“thymosin beta 4 really promotes the growth and infiltration of all sorts of different cell types associated with tissue rejuvenation and especially wound healing and repair. It's been shown to promote stem cell proliferation. It's been shown to increase the growth of the so-called extracellular matrix...the idea is that thymosin beta 4 is promoting the aggregation of a bunch of things associated with tissue healing.”
Huberman personally took sermorelin for a couple of years on and off, typically 1-2 nights per week, but stopped because it increased deep sleep at the expense of rapid eye movement (REM) sleep, and he wanted to maintain REM sleep which is critical for functions that deep sleep cannot achieve.
“I'll be completely forthcoming. I've taken sermorelin on and off for the last couple of years. I typically will take it anywhere from one to two nights per week. And I stopped taking it almost completely...it made the sleep in the early part of my night very, very deep, very robust. But then I would wake up wide awake...I wasn't getting nearly as much rapid eye movement sleep as I normally would...it seemed to sort of replace rapid eye movement sleep with more deep sleep...rapid eye movement sleep is critical for all sorts of things that deep sleep can't achieve”
A peptide is defined as a small protein consisting of short chains of amino acids, strictly two to 50 amino acids, though peptides of 75-100 amino acids are sometimes still considered peptides; combining peptides yields polypeptides, and the order of amino acids along the chain determines what the peptide is and does.
“The basic way that we define a peptide is that it tends to be a small protein, meaning chains of anywhere from two to 50 amino acids.”
Children heal from wounds much faster and with less scarring than adults, which is attributed in part to higher growth hormone, secretions from the thymus (like thymosin beta 4), and other factors; this developmental observation is the rationale underlying both tissue-repair peptides and the logic of taking thymus- and pineal-derived peptides in adulthood.
“it's well known that children recover more quickly from injuries. And indeed, the degree of tissue regrowth and the repair of wounds with minimal scarring is so much greater in young children”
BPC-157 typical dosing is 300 to 500 micrograms administered subcutaneously or intramuscularly, 2 to 3 times per week (or up to 5 days per week), typically for a course of about 8 weeks, followed by cycling off for 8 to 10 weeks, though some individuals take it continuously without breaks.
“The typical therapeutic doses that are prescribed are anywhere from 300 to 500 micrograms subcutaneously, maybe two or three times per week. And that is typically done for a course of about 8 weeks, and then people typically cycle off for anywhere from 8 to 10 weeks.”
MK-677 is an oral non-injectable version of GHRPs that has the same issues as other GHRPs including elevated cortisol and in some cases elevated prolactin.
“many people have perhaps heard of what's called MK-677, which is simply an oral version, a non-injectable but oral version of these GHRPs. And it tends to have the same issues that the other GHRPs have, which are elevated cortisol and in some cases elevated prolactin as well.”
Growth hormone secretagogues are typically taken before bed (20-30 minutes before sleep), at least 1.5 hours after eating food, and without eating for at least 30 minutes afterward, because elevated blood sugar or food in the gut reduces the potency of these peptides in increasing growth hormone and IGF-1.
“almost always these growth hormone peptides, whether or not they're type one or type two peptides, are taken before bed, typically, you know, 20 or 30 minutes before sleep. Always it's suggested that they be taken at least an hour and a half after eating any food...you don't eat for at least 30 minutes afterwards because if you happen to have elevated blood sugar or you've got food in your gut, they're not going to have as potent an effect at increasing growth hormone and IGF-1.”
There is a long historical medical practice of placing severed fingers, hands, or other tissues into the stomach environment to preserve them and keep them alive for later grafting, which gave rise to the theory that something within gastric juices or the gut itself promotes tissue preservation and healing.
“There's a very long and kind of interesting history of the use of gastric juices. Okay, I know the term might make a few people queasy, but gastric juices to promote tissue healing and repair...one can find in the historical medical literature instances of people say severing off a finger or even a hand or things of that sort and then it being placed by a surgeon, of course, or in some cases these were battlefield situations into the gut as a way to preserve that finger or hand and keep it alive essentially and then to graft it back on”
BPC-157 (body protection compound 157) is a synthetic peptide manufactured in laboratories to resemble a naturally-occurring peptide within the gut that is involved in wound healing and repair.
“BPC, which stands for body protection compound 157. BPC 157 is a synthetic peptide. It's manufactured in a laboratory to resemble a peptide that exists naturally within our gut.”
The gut lining has frequent cell turnover at a pretty frequent rate, unlike brain cells which mostly remain stable after age 25, and this constant turnover is similar to the tissue repair process that occurs during wound healing.
“the lining of your gut all along its length involves a bunch of different layers of cells that turn over at a pretty frequent rate. So, unlike your brain cells that for instance, after about age 25, you're not adding or deleting many brain cells...your gut is very different. Within the milieu of the gut, you have a lot of turnover of cells. And the turnover of cells in the gut is in many ways the same sort of turnover process that's involved in wound healing and repair.”
TB-500 is a truncated or shortened synthesized version of thymosin beta 4 that acts similarly to the full-length peptide but has a different mode of action and lasts longer in the body.
“TB500, which is basically a truncated or a shortened version of the thymosin beta 4 peptide...acts similarly to thymosin beta 4, but has a kind of different mode of action, lasts a little bit longer, etc.”
Growth hormone is naturally secreted from the pituitary gland and is released in particularly high amounts during early hours of sleep, particularly in infants, children, and teenagers, and this high release drives physical growth and tissue development.
“growth hormone is a hormone that we naturally make. It's secreted from a gland called the pituitary gland...early in life, when we are infants, children, teenagers, and so on, we secrete tons of growth hormone, in particular, during the early hours of sleep each night...it's really in sleep in which we have the greatest degree of growth hormone release. This is one reason why babies and kids and teenagers sleep so much is there's a lot of growth hormone release and we tend to grow”
IGF-1 (insulin-like growth factor 1) is produced by the liver in response to growth hormone and produces synergistic and parallel effects to growth hormone including tissue repair, growth, and blood sugar metabolism regulation.
“There's another hormone called IGF-1 or insulin growth factor 1, which is produced by the liver. Insulin growth factor 1 does many things similar to growth hormone and it actually is released in response to growth hormone...When growth hormone reaches the liver, it stimulates the release of IGF-1, which in turn does a number of things that are both synergistic and different.”
The pineal gland, despite being very small (about the size of a pea), releases melatonin each night in darkness and epithalamin, and these compounds contribute to restorative features of sleep including reduction of tissue inflammation and cellular repair.
“The pineal gland, despite being very, very small, about the size of a pea...What it does is it will release melatonin each night in darkness. It can release epithalamin. And at those times it can go and have these myriad effects on restoring the brain and body during sleep.”
Kisspeptin is a naturally-made peptide within the brain that is upstream of hypothalamic signals and activates the pituitary for hormone production and reproduction, and was not discovered very long ago.
“Kisspeptin is a peptide that wasn't discovered that long ago. I actually can recall when the first papers about kisspeptin came out. And basically, kisspeptin is a peptide that is naturally made within the brain, and it's upstream of some of the hypothalamic signals that activate the pituitary for sake of hormone production and reproduction.”
A peptide is a small protein made up of chains of amino acids, typically defined as chains of 2 to 50 amino acids, though peptides up to 75-100 amino acids are sometimes included in this category.
“A peptide is a small protein that's made up of little chains of amino acids...The basic way that we define a peptide is that it tends to be a small protein, meaning chains of anywhere from two to 50 amino acids. That's really the strict definition of a peptide. However, oftentimes peptides that are a little bit bigger, so maybe 75 or 100 amino acids in length, will also be considered a peptide.”
Peptides exist within the tens of thousands, if not hundreds of thousands, of different varieties within our brain and body, including insulin for blood glucose regulation and oxytocin for pair bonding and socialization.
“and that exist within the tens of thousands, if not hundreds of thousands, of different peptides that exist within our brain and body...insulin, which is involved in regulating our blood sugar or blood glucose levels, is a peptide. Oxytocin, which is sometimes called the love hormone...it's a neuropeptide/hormone that is involved in everything from pair bonding to socialization”
Huberman has not suggested anyone run out and take BPC-157 or other peptides; rather, the episode is about providing information so people can make their own determination about whether to use peptides, while seriously considering sourcing issues.
“I want to also state that I am not suggesting anyone run out and take BPC 157. Today's episode is really about giving you information so that you can make the determination whether or not you even want to take BPC 157 or another peptide, and of course to really seriously consider the sourcing issue that we talked about earlier.”
The general pattern of melanotan 2, 3, 4, and 5 effects is to increase mood, increase libido, and decrease appetite, effects associated with the transition from winter to spring and summer months in humans and other animals.
“In general the pattern is to increase mood and libido and to decrease appetite. Things are associated with the transition from winter to spring and summer months in humans and in other animals.”
There are various theories about why the pineal regresses with age, ranging from wild theories about fluoride depletion to more evidence-based explanations that are starting to gain support in the scientific community.
“There are a bunch of theories as to why the pineal regresses with age. There's some kind of wild ones about fluoride and a depletion of the of the pineal. I'll do a whole episode on the pineal at some point and we'll explore that. Some of them are very niche, some of them are frankly completely false, and others have some merit and are starting to um gain some data within the standard scientific community.”
Huberman is excited about the potential of peptide therapeutics for both treatment of disease and augmentation of mental and physical health, and sees peptide therapeutics as an exciting landscape worth exploring further on the podcast with expert guests and solo episodes.
“it's very exciting to see what's happening with peptide therapeutics. I'm excited about their potential for both the treatment of disease as well as for augmentation of mental and physical health, and I think it's an exciting landscape that certainly motivated uh my desire to do this episode and get you familiar with them, or at least with some of them. And it's something that we're definitely going to be exploring more on this podcast, both with expert guests and in solo episodes going forward.”
Insulin and oxytocin are examples of peptides familiar to most people; oxytocin is sometimes called the love hormone but that is not the best description.
“insulin, which is involved in regulating our blood sugar... is a peptide. Oxytocin, which is sometimes called the love hormone”
Today we are discussing peptides, and I will explain what a peptide is in a few moments.
“Today, we are discussing peptides.”